Purpose: To evaluate the efficacy and safety of proton beam therapy (PBT) for patients with hepatocellular carcinoma (HCC) located adjacent to the porta hepatis.
Methods And Materials: Subjects of the study were 53 patients with HCC located within 2 cm of the main portal vein. All patients had tumor confined to the radiation field with no evidence of metastatic disease. All patients had hepatic function levels of a Child-Pugh score of 10 or less, Eastern Cooperative Oncology Group performance status of 2 or less, and no uncontrolled ascites. Patients underwent PBT of 72.6 GyE in 22 fractions from Sept 2001 to Dec 2004.
Results: After 3 years, the actuarial survival rate was 45.1% and local control rate was 86.0%. Prognostic factors for survival included Child-Pugh score, number of tumors, and alpha-fetoprotein levels. No late treatment-related toxicity of Grade 2 or higher was observed.
Conclusions: The PBT delivering 72.6 GyE in 22 fractions appears to be effective and safe for HCC adjacent to the porta hepatis.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ijrobp.2007.09.056 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A retrospective study of irreversible electroporation for tumors adjacent to perihepatic important structure.
Front Oncol
September 2024
Department of Interventional Radiology, Ruijin Hospital Luwan Branch, Shanghai JiaoTong University School of Medicine, Shanghai, China.
Article Synopsis
- * This study analyzed the outcomes of 32 patients with tumors close to these important structures who underwent IRE treatment from 2017 to 2021, using follow-up imaging to track complications and survival rates.
- * Results indicated that IRE was successfully applied to various tumor locations, with a significant portion of lesions located near the porta hepatis and a minority adjacent to the gallbladder, showcasing the potential for expanding IRE's use in challenging clinical settings.
RNASEH2B loss and PARP inhibition in advanced prostate cancer.
J Clin Invest
June 2024
The Institute of Cancer Research, London, United Kingdom.
BACKGROUNDClinical trials have suggested antitumor activity from PARP inhibition beyond homologous recombination deficiency (HRD). RNASEH2B loss is unrelated to HRD and preclinically sensitizes to PARP inhibition. The current study reports on RNASEH2B protein loss in advanced prostate cancer and its association with RB1 protein loss, clinical outcome, and clonal dynamics during treatment with PARP inhibition in a prospective clinical trial.
View Article and Find Full Text PDFMicrocystic serous cystadenoma of the pancreas causing biliary obstruction: a case report and review of the literature.
J Surg Case Rep
March 2024
Alabama Oncology, Grandview Medical Center, Birmingham AL 35243, United States.
Cystic tumors account for 15% of pancreatic tumors. Of these, serous microcystic adenomas represent 1-2% of pancreatic exocrine neoplasms. While typically benign, a small percentage possess malignant potential.
View Article and Find Full Text PDFRobotic Klatskin Type 3A Resection with Biliary Reconstruction: Description of Surgical Technique and Outcomes of Initial Series.
Ann Surg Oncol
December 2023
AdventHealth Tampa, Digestive Health Institute, Tampa, FL, USA.
Introduction: Minimally invasive resection for perihilar cholangiocarcinoma is an emerging technique that requires both mastery in minimally invasive liver resection and biliary reconstruction. Due to technical difficulties in biliovascular dissection, radical portal lymphadenectomy and the need for fine suturing during bilioenteric anastomosis, this type of resection is generally not performed laparoscopically, even at high-volume, liver-surgery centers. In modern literature, a detailed, operative description of robotic technique for this operation with outcome data is lacking.
View Article and Find Full Text PDFComputed tomography of suppurative and neoplastic diseases involving the canine omenta and omental bursa.
Vet Radiol Ultrasound
September 2023
Department of Clinical Sciences, Cornell University, Ithaca, New York, USA.
The greater and lesser omenta are fused peritoneal folds that largely delimit the omental bursa (lesser peritoneal cavity). The omental bursa is a potential space within the abdominal cavity that communicates with the greater peritoneal cavity via the omental (epiploic) foramen: it is subdivided into the omental vestibule, caudal omental recess, and splenic recess. Aims of this retrospective case series study were to describe the frequencies of CT findings of dogs with confirmed inflammatory or neoplastic disease of the omenta, omental bursa, or both.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!